Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Saxenda
Pharma
Teva launches first generic version of Novo's GLP-1 Saxenda
Patients in the U.S. now have access to the first generic GLP-1 treatment approved for weight loss as Teva has launched its version of Saxenda.
Kevin Dunleavy
Aug 28, 2025 3:45pm
Novo asks FDA to restrict compounding of legacy GLP-1 Victoza
Jan 3, 2025 3:25pm
Novo Nordisk scolded yet again by UK drug marketing watchdog
Sep 26, 2024 10:46am
Novo weight-loss drugs pose risk of stomach problems: study
Oct 6, 2023 12:55pm
Increased demand squeezes supplies of Eli Lilly's Mounjaro—again
Jul 26, 2023 9:57am
Lawmakers, Big Pharmas push for Medicare obesity drug coverage
Jul 20, 2023 3:01pm
